enteralogo.png
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
March 08, 2024 16:05 ET | Entera Bio Ltd.
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results...
enteralogo.png
Entera Bio to Participate in Upcoming Investor Conferences
September 05, 2023 08:00 ET | Entera Bio Ltd.
JERUSALEM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
enteralogo.png
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
August 11, 2023 16:05 ET | Entera Bio Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...